Angiotensin-converting enzyme gene polymorphism and vascular manifestations in Korean patients with SLE

Lupus

Volumn 11, Issue 4, 2002, Pages 227-233

  Uhm, W S ^a   Lee, H S ^a   Chung, Y H ^a   Kim, T H ^a   Bae, S C ^a   Joo, K B ^a   Kim, T Y ^a   Yoo, D H ^a  

^a Hanyang University Hospital for Rheumatic Diseases   (South Korea)

Author keywords

ACE gene insertion deletion (I D) polymorphism; Activity index; Korean; Raynaud's phenomenon; Systemic lupus erythematosus; Vasculitis

Indexed keywords

ANGIOTENSIN RECEPTOR; AUTOANTIBODY; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; NITRIC OXIDE; PROTEIN; SM ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY TITER; ARTICLE; CHRONICITY; COMORBIDITY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; INFLAMMATION; KIDNEY FAILURE; LIVEDO RETICULARIS; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RASH; RAYNAUD PHENOMENON; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULAR DISEASE;

ADULT; CARDIOVASCULAR ABNORMALITIES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; KOREA; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 0036250763     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203302lu174oa     Document Type: Article

References (39)

1. The genetics of lupus
2. Angiotensin I converting enzyme gene is on chromosome 17
3. An insertion/deletion polymorphism in the angiotensinI-converting enzyme gene accounting for half the variance of serum enzyme levels
4. Association between systemic lupus erythematosus and insertion/deletion polymorphism of the angiotensin converting enzyme (ACE) gene
5. Angiotensin-converting enzyme insertion/deletion polymorphism and cerebrovascular disease
6. Association between angiotensin converting enzyme gene polymorphism and carotid atherosclerosis
7. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus
8. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group
9. Genetic risk for renal artery stenosis: Association with deletion polymorphism in angiotensin 1-converting enzyme gene
10. Angiotensin converting enzyme as a genetic risk factor for coronary artery spasm. Implication in the pathogenesis of myocardial infarction
11. Linkage analysis of angiotensin-converting enzyme (ACE) insertion/deletion polymorphism and systemic lupus erythematosus
12. Vasoactive hormone and renal sclerosis
13. Assessment of kinases in rheumatic diseases and the effect of therapeutic agents
14. DD angiotensin-converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans
15. The 1982 revised criteria for the classification of systemic lupus erythematosus
16. Kidney biopsy in SLE. I. A clinical-morphologic evaluation
17. Diffuse proliferative lupus nephritis: Identification of specific pathologic features affecting renal outcome
18. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus
19. Systemic lupus international collaborative clinics: Development of a damage index in systemic lupus erythematosus
20. Association between systemic lupus erythematosus and insertion/deletion polymorphism of the angiotensin converting enzyme (ACE) gene
21. An evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of arterial thrombosis in patients with the antiphospholipid syndrome
22. Renal outcome and vascular morbidity in systemic lupus erythematosus (SLE): Lack of association with the angiotensin-converting enzyme gene polymorphism
23. Increased prostacyclin metabolites and decreased red cell deformability in patients with systemic sclerosis and Raynauds syndrome
24. Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon
25. Clinical correlations of plasma angiotensin converting enzyme (ACE) activity in systemic sclerosis: A longitudinal study of plasma ACE level, endothelial injury and lung involvement
26. Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's phenomenon
27. Reduced angiotensin converting enzyme plasma activity in scleroderma. A marker of endothelial injury?
28. Angiotensin I converting enzyme gene polymorphisms in systemic lupus erythematosus: Decreased prevalence of DD genotype in African American patients
29. Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy
30. Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus
31. Angiotensin-converting enzyme gene polymorphism and the clinical pathological features and progression in lupus nephritis
32. Association of an insertion polymorphism of angiotensin-converting enzyme gene with the activity of lupus nephritis
33. Association of an insertion polymorphism of angiotensin-converting enzyme gene with the activity of systemic lupus erythematosus
34. Enhancement of phagocytosis - A newly found activity of substance P residing in its N-terminal tetrapeptide sequence
35. Bradykinin stimulates bronchial epithelial cells to release neutrophil and monocyte chemotactic activity
36. Effect of neuropeptides on production of inflammatory cytokines by human monocytes
37. Neuropeptides and inflammation: The role of substance P